Newsroom

Industry News

24 Jul

Cytori Announces Top-Line 24- and 48-Week Results from the STAR Trial of Habeo™ Cell Therapy in Patients with Scleroderma

Statistical significance not achieved in primary or secondary efficacy endpoints Clinically meaningful efficacy trends observed in primary and secondary endpoints in pre-specified diffuse cutaneous scleroderma subgroup No significant safety related issues Conference call scheduled for 8:30am EDT  SAN DIEGO, July 24, 2017 (GLOBE NEWSWIRE) — Cytori Therapeutics, Inc. (CYTX)...

Read more

20 Jul

Siyata Mobile Partners with Nexar, the World’s First Vehicle-to-Vehicle Network

Combined Offering Connects Commercial Vehicles for Safer and Accountable Driving Behaviours Montréal, QC – Siyata Mobile Inc. (TSX-V:SIM | OTCQB: SYATF) (the “Company” or “Siyata”) today announces that it has entered into an integration and resale partnership with Nexar Inc, a community-based artificial intelligence (AI) dash cam application. Founded in early 2015, Nexar’s mission is to...

Read more

18 Jul

Inovio Announces Proposed Public Offering of Common Stock

PLYMOUTH MEETING, Pa., July 18, 2017 (GLOBE NEWSWIRE) — Inovio Pharmaceuticals, Inc. (INO) today announced that it intends to offer and sell $75.0 million of shares of its common stock in an underwritten public offering.  Inovio expects to grant the underwriters an option to purchase up to an additional...

Read more

18 Jul

Moleculin Signs Agreement with MD Anderson Cancer Center for Leukemia Drug, Annamycin

HOUSTON, TX–(Marketwired – July 18, 2017) – Moleculin Biotech, Inc., (MBRX)(“Moleculin” or the “Company”), a preclinical pharmaceutical company focused on the development of anti-cancer drug candidates, some of which are based on license agreements with The University of Texas System on behalf of the M.D. Anderson Cancer Center, today announced it...

Read more

17 Jul

NEMUS Bioscience Announces NB2222 Pain and Anti-Addiction Data Accepted for Presentation at Upcoming Society of Neuroscience Meeting

COSTA MESA, CA–(Marketwired – Jul 17, 2017) – NEMUS Bioscience, Inc. ( OTCQB :NMUS ) announced that data recently obtained from the company’s research and development partner, the University of Mississippi (UM), was accepted for presentation at the 2017 Annual Meeting of the Society of Neuroscience held in Washington, D.C. on November 11th-15th. The data...

Read more

Page 1 of 24412345...102030...Last »

Enter your email address to receive notifications of new posts by email.

Latest Tweets

Follow

Follow this blog

Get every new post delivered right to your inbox.

Email address